Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4396 USD | -0.54% | +2.23% | -40.60% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.65M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on NeuBase Therapeutics, Inc.
1 day | -0.54% | ||
1 week | +2.23% | ||
Current month | -2.29% | ||
1 month | -8.19% | ||
3 months | -30.28% | ||
6 months | -30.64% | ||
Current year | -40.60% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4396 | -0.54% | 72,170 |
24-04-25 | 0.442 | +4.99% | 25,641 |
24-04-24 | 0.421 | 0.00% | 21,218 |
24-04-23 | 0.421 | +0.24% | 58,425 |
24-04-22 | 0.42 | -2.33% | 157,792 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.60% | 1.65M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NBSE Stock